β-Lactam vs Non–β-Lactam Prophylaxis in Elective Colorectal Surgery
JAMA Network Open · 2026
DOI: 10.1001/jamanetworkopen.2026.6708 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2026. Verfasst von Curtis D Collins und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Trinity Health Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Antibiotic Prophylaxis, beta-Lactams, Elective Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Previous studies found reduced surgical site infections (SSIs) with β-lactam surgical infection prophylaxis compared with non–β-lactam alternatives; however, variations in timing and dosing have been reported. Whether guideline-concordant preoperative antibiotic dosing or timing are associated with reported SSI differences between regimens is unclear.
Objective
To evaluate the incidence of SSIs between patients receiving β-lactam and non–β-lactam alternative prophylaxis, while controlling guideline-concordant dosing and timing. Design, Setting, and Participants This multicenter retrospective cohort study used data from a validated regional data registry. Adult patients (>18 years) receiving β-lactam and non–β-lactam alternative prophylaxis for elective colorectal surgery between July 2012 and June 2021 were included. Analyses were performed at multiple intervals between March 2022 and January 2026. Exposures Surgical prophylaxis regimens with β-lactam or non–β-lactam alternative prophylaxis. Receipt of guideline-concordant prophylaxis dose and timing were variables of interest, defined using international guideline recommendations. Main Outcomes and Measures The primary outcome was 30-day SSI. Modified Poisson regression with robust (sandwich) variance estimators was used to estimate adjusted risk ratios (ARRs) for SSI comparing β-lactam with non–β-lactam alternative prophylaxis, adjusting for guideline-concordant dosing, timing, and other covariates; 1:1 propensity score matching was performed as a sensitivity analysis.
Results
Among 20 140 procedures (female, 10 423 [51.8%]; male, 9717 [48.2%]; mean [SD] age, 62.0 [13.8] years), 18 098 (89.9%) received β-lactam prophylaxis and 2042 (10.1%) received non–β-lactam alternative prophylaxis. Baseline characteristics differed between groups. Patients in the β-lactam cohort more commonly received guideline-concordant antibiotic dosing (15 124 [83.6%] vs 1084 [53.1%]; P < .001), guideline-concordant timing (16 946 [93.6%] vs 1707 [83.6%]; P < .001), or combined guideline-concordant dose and timing (14 216 [78.6%] vs 751 [36.8%]; P < .001), and had fewer SSIs (1114 [6.2%] vs 172 [8.4%]; P < .001). After adjusting for confounders, β-lactam prophylaxis was associated with a lower risk of SSIs (ARR, 0.74; 95% CI, 0.63-0.87; P < .001). Neither guideline-concordant dosing (ARR, 1.04; 95% CI, 0.91-1.20; P = .54) nor timing (ARR, 1.13; 95% CI, 0.92-1.38; P = .25) were associated with SSI risk. Conclusions and Relevance In this cohort study of elective colorectal surgery procedures, β-lactam surgical prophylaxis was associated with significantly lower SSI risk compared with non–β-lactam alternatives. Differences in guideline-concordant dosing and timing between cohorts were not associated with SSI risk in adjusted analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Services, Trinity Health Ann Arbor, Michigan.
- Department of Colon and Rectal Surgery, Trinity Health Ann Arbor, Michigan.
- Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan.
- Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan.
Zitieren
APA
Collins, C. D., Hartsfield, E., Cleary, R. K., Veve, M. P., & Brockhaus, K. K. (2026). β-Lactam vs Non–β-Lactam Prophylaxis in Elective Colorectal Surgery. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.6708
Vancouver
Collins CD, Hartsfield E, Cleary RK, Veve MP, Brockhaus KK. β-Lactam vs Non–β-Lactam Prophylaxis in Elective Colorectal Surgery. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.6708
BibTeX
@article{Collins2026,
author = {Collins, Curtis D and Hartsfield, Eric and Cleary, Robert K and Veve, Michael P and Brockhaus, Kara K},
title = {β-Lactam vs Non–β-Lactam Prophylaxis in Elective Colorectal Surgery},
journal = {JAMA Network Open},
year = {2026},
doi = {10.1001/jamanetworkopen.2026.6708}
}
EUVIMED